Vitaspring Biomedical Gross Margin Growth & History (VSBC)

Vitaspring Biomedical's gross margin was 36.84% for fiscal 2022.

View full Vitaspring Biomedical company overview

Vitaspring Biomedical annual gross margin history

Vitaspring Biomedical annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20222022-01-3136.84%−8.36 pp
20212021-01-3145.21%+34.01 pp
20202020-01-3111.20%−68.65 pp
20192019-01-3179.85%+9.97 pp
20182018-01-3169.88%

Vitaspring Biomedical gross margin trends

Across the available reported history, Vitaspring Biomedical's gross margin decreased from 45.21% to 36.84%, a change of −8.36 percentage points. The latest reported quarter, Q1 2023, shows 38.12%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Vitaspring Biomedical filings at SEC.gov ↗